141 related articles for article (PubMed ID: 19808652)
1. Correlation of CXCL12 expression and FoxP3+ cell infiltration with human papillomavirus infection and clinicopathological progression of cervical cancer.
Jaafar F; Righi E; Lindstrom V; Linton C; Nohadani M; Van Noorden S; Lloyd T; Poznansky J; Stamp G; Dina R; Coleman DV; Poznansky MC
Am J Pathol; 2009 Oct; 175(4):1525-35. PubMed ID: 19808652
[TBL] [Abstract][Full Text] [Related]
2. Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis.
Litwin TR; Irvin SR; Chornock RL; Sahasrabuddhe VV; Stanley M; Wentzensen N
Br J Cancer; 2021 Feb; 124(4):831-841. PubMed ID: 33257839
[TBL] [Abstract][Full Text] [Related]
3. Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer.
Loddenkemper C; Hoffmann C; Stanke J; Nagorsen D; Baron U; Olek S; Huehn J; Ritz JP; Stein H; Kaufmann AM; Schneider A; Cichon G
Cancer Sci; 2009 Jun; 100(6):1112-7. PubMed ID: 19514119
[TBL] [Abstract][Full Text] [Related]
4. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
5. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.
Piersma SJ; Jordanova ES; van Poelgeest MI; Kwappenberg KM; van der Hulst JM; Drijfhout JW; Melief CJ; Kenter GG; Fleuren GJ; Offringa R; van der Burg SH
Cancer Res; 2007 Jan; 67(1):354-61. PubMed ID: 17210718
[TBL] [Abstract][Full Text] [Related]
6. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.
Sheu BC; Chang WC; Lin HH; Chow SN; Huang SC
J Obstet Gynaecol Res; 2007 Apr; 33(2):103-13. PubMed ID: 17441881
[TBL] [Abstract][Full Text] [Related]
7. HPV16 tumor associated macrophages suppress antitumor T cell responses.
Lepique AP; Daghastanli KR; Cuccovia IM; Villa LL
Clin Cancer Res; 2009 Jul; 15(13):4391-400. PubMed ID: 19549768
[TBL] [Abstract][Full Text] [Related]
8. Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions.
Gopalkrishna V; Aggarwal N; Malhotra VL; Koranne RV; Mohan VP; Mittal A; Das BC
Clin Microbiol Infect; 2000 Feb; 6(2):88-93. PubMed ID: 11168078
[TBL] [Abstract][Full Text] [Related]
9. Local immune response depends on p16INK4a status of primary tumor in vulvar squamous cell carcinoma.
Sznurkowski JJ; Żawrocki A; Biernat W
Oncotarget; 2017 Jul; 8(28):46204-46210. PubMed ID: 28515351
[TBL] [Abstract][Full Text] [Related]
10. Stromal Fibroblasts Induce CCL20 through IL6/C/EBPβ to Support the Recruitment of Th17 Cells during Cervical Cancer Progression.
Walch-Rückheim B; Mavrova R; Henning M; Vicinus B; Kim YJ; Bohle RM; Juhasz-Böss I; Solomayer EF; Smola S
Cancer Res; 2015 Dec; 75(24):5248-59. PubMed ID: 26631268
[TBL] [Abstract][Full Text] [Related]
11. Increased High-Risk Human Papillomavirus Viral Load Is Associated With Immunosuppressed Microenvironment and Predicts a Worse Long-Term Survival in Cervical Cancer Patients.
Cao M; Wang Y; Wang D; Duan Y; Hong W; Zhang N; Shah W; Wang Y; Chen H
Am J Clin Pathol; 2020 Mar; 153(4):502-512. PubMed ID: 31819948
[TBL] [Abstract][Full Text] [Related]
12. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type 33 E7 peptides presented by HLA-DR*0402 to tumor-infiltrating T cells in cervical cancer.
Höhn H; Pilch H; Günzel S; Neukirch C; Freitag K; Necker A; Maeurer MJ
J Virol; 2000 Jul; 74(14):6632-6. PubMed ID: 10864677
[TBL] [Abstract][Full Text] [Related]
14. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix.
Grace VM; Shalini JV; lekha TT; Devaraj SN; Devaraj H
Gynecol Oncol; 2003 Oct; 91(1):51-8. PubMed ID: 14529662
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers.
Woo JW; Chung YR; Kim M; Choi HY; Ahn S; Park SY
Cancer Immunol Immunother; 2021 May; 70(5):1365-1378. PubMed ID: 33146829
[TBL] [Abstract][Full Text] [Related]
16. CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia.
Molling JW; de Gruijl TD; Glim J; Moreno M; Rozendaal L; Meijer CJ; van den Eertwegh AJ; Scheper RJ; von Blomberg ME; Bontkes HJ
Int J Cancer; 2007 Oct; 121(8):1749-55. PubMed ID: 17582606
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7.
Nonn M; Schinz M; Zumbach K; Pawlita M; Schneider A; Dürst M; Kaufmann AM
J Cancer Res Clin Oncol; 2003 Sep; 129(9):511-20. PubMed ID: 12905010
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus 16 E6-specific CD45RA+ CCR7+ high avidity CD8+ T cells fail to control tumor growth despite interferon-gamma production in patients with cervical cancer.
Zehbe I; Kaufmann AM; Schmidt M; Hohn H; Maeurer MJ
J Immunother; 2007; 30(5):523-32. PubMed ID: 17589293
[TBL] [Abstract][Full Text] [Related]
19. Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element.
Piersma SJ; Welters MJ; van der Hulst JM; Kloth JN; Kwappenberg KM; Trimbos BJ; Melief CJ; Hellebrekers BW; Fleuren GJ; Kenter GG; Offringa R; van der Burg SH
Int J Cancer; 2008 Feb; 122(3):486-94. PubMed ID: 17955486
[TBL] [Abstract][Full Text] [Related]
20. CXCL12/CXCR4 axis gene variants contribute to an increased vulnerability to HPV infection and cervical oncogenesis.
Okuyama NCM; Cezar-Dos-Santos F; Trugilo KP; Esposito A; Guembarovski RL; Couto-Filho JD; Watanabe MAE; de Oliveira KB
J Cancer Res Clin Oncol; 2022 Apr; 148(4):793-802. PubMed ID: 35083551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
